AT296660T - An apparatus for local administration of a drug - Google Patents

An apparatus for local administration of a drug

Info

Publication number
AT296660T
AT296660T AT95910886T AT95910886T AT296660T AT 296660 T AT296660 T AT 296660T AT 95910886 T AT95910886 T AT 95910886T AT 95910886 T AT95910886 T AT 95910886T AT 296660 T AT296660 T AT 296660T
Authority
AT
Austria
Prior art keywords
drug
apparatus
local administration
administration
local
Prior art date
Application number
AT95910886T
Other languages
German (de)
Inventor
Stephen R Hanson
Neal A Scott
Spencer B King Iii
Laurence A Harker
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/188,248 priority Critical patent/US5523092A/en
Application filed by Univ Emory filed Critical Univ Emory
Priority to PCT/US1995/001080 priority patent/WO1995020416A1/en
Publication of AT296660T publication Critical patent/AT296660T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0102Insertion or introduction using an inner stiffening member, e.g. stylet or push-rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0063Catheters; Hollow probes characterised by structural features having means, e.g. stylets, mandrils, rods or wires to reinforce or adjust temporarily the stiffness, column strength or pushability of catheters which are already inserted into the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0041Catheters; Hollow probes characterised by the form of the tubing pre-formed, e.g. specially adapted to fit with the anatomy of body channels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
AT95910886T 1993-04-14 1995-01-27 An apparatus for local administration of a drug AT296660T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US08/188,248 US5523092A (en) 1993-04-14 1994-01-28 Device for local drug delivery and methods for using the same
PCT/US1995/001080 WO1995020416A1 (en) 1994-01-28 1995-01-27 A device for local drug delivery and methods for using the same

Publications (1)

Publication Number Publication Date
AT296660T true AT296660T (en) 2005-06-15

Family

ID=22692364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910886T AT296660T (en) 1993-04-14 1995-01-27 An apparatus for local administration of a drug

Country Status (11)

Country Link
US (2) US5523092A (en)
EP (1) EP0754072B1 (en)
JP (1) JPH10500028A (en)
AT (1) AT296660T (en)
AU (1) AU682582B2 (en)
CA (1) CA2182201A1 (en)
DE (2) DE69534245D1 (en)
DK (1) DK0754072T3 (en)
ES (1) ES2243934T3 (en)
PT (1) PT754072E (en)
WO (1) WO1995020416A1 (en)

Families Citing this family (399)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5985307A (en) 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US6231600B1 (en) 1995-02-22 2001-05-15 Scimed Life Systems, Inc. Stents with hybrid coating for medical devices
US6558798B2 (en) 1995-02-22 2003-05-06 Scimed Life Systems, Inc. Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
US6451047B2 (en) * 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
US6579314B1 (en) * 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
US6264684B1 (en) 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
US6743198B1 (en) * 1995-03-20 2004-06-01 Conticare Medical, Inc. Self-cleansing bladder drainage device
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US6322548B1 (en) 1995-05-10 2001-11-27 Eclipse Surgical Technologies Delivery catheter system for heart chamber
US5779673A (en) * 1995-06-26 1998-07-14 Focal, Inc. Devices and methods for application of intraluminal photopolymerized gels
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6402736B1 (en) * 1996-02-16 2002-06-11 Joe E. Brown Apparatus and method for filtering intravascular fluids and for delivering diagnostic and therapeutic agents
US5603694A (en) * 1995-10-17 1997-02-18 Brown; Joe E. Infusion coil apparatus and method for delivering fluid-based agents intravascularly
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US6379334B1 (en) * 1997-02-10 2002-04-30 Essex Technology, Inc. Rotate advance catheterization system
AU6162498A (en) * 1997-02-14 1998-09-08 Joe E. Brown Coil apparatus and method for delivering diagnostic and therapeutic agents intravascularly
SG64340A1 (en) * 1996-02-27 1999-04-27 Inst Of Systems Science Nation Curved surgical instruments and methods of mapping a curved path for stereotactic surgery
EP1616563A3 (en) 1996-05-24 2006-01-25 Angiotech Pharmaceuticals, Inc. Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases
US6190402B1 (en) * 1996-06-21 2001-02-20 Musc Foundation For Research Development Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5944701A (en) * 1996-10-03 1999-08-31 Dubrul; William R. Self coiling catheter
US7341598B2 (en) * 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US8574220B2 (en) 2006-02-28 2013-11-05 Olympus Endo Technology America Inc. Rotate-to-advance catheterization system
US8414477B2 (en) 2005-05-04 2013-04-09 Olympus Endo Technology America Inc. Rotate-to-advance catheterization system
US7780650B2 (en) 2005-05-04 2010-08-24 Spirus Medical, Inc. Rotate-to-advance catheterization system
US8235942B2 (en) 2005-05-04 2012-08-07 Olympus Endo Technology America Inc. Rotate-to-advance catheterization system
US8435229B2 (en) 2006-02-28 2013-05-07 Olympus Endo Technology America Inc. Rotate-to-advance catheterization system
WO2006093976A1 (en) 2005-02-28 2006-09-08 Spirus Medical Inc. Rotate-to-advance catheterization system
US7048717B1 (en) 1999-09-27 2006-05-23 Essex Technology, Inc. Rotate-to-advance catheterization system
US8317678B2 (en) 2005-05-04 2012-11-27 Olympus Endo Technology America Inc. Rotate-to-advance catheterization system
US8343040B2 (en) 2005-05-04 2013-01-01 Olympus Endo Technology America Inc. Rotate-to-advance catheterization system
JP3274384B2 (en) * 1997-03-31 2002-04-15 株式会社パイオラックス Indwelling catheter and insertion device
US5865815A (en) * 1997-04-25 1999-02-02 Contimed, Inc. Prostatic obstruction relief catheter
IT1293973B1 (en) 1997-08-13 1999-03-15 Sorin Biomedica Cardio Spa Element for the anchorage in situ of implant devices.
US6012034A (en) * 1997-08-18 2000-01-04 Becton, Dickinson And Company System and method for selecting an intravenous device
US20020055717A1 (en) * 1997-10-20 2002-05-09 Philippe Poncet Fluid-based agent delivery device with self-expanding delivery element
US6241691B1 (en) 1997-12-05 2001-06-05 Micrus Corporation Coated superelastic stent
US6159165A (en) * 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6168570B1 (en) 1997-12-05 2001-01-02 Micrus Corporation Micro-strand cable with enhanced radiopacity
US6358229B1 (en) * 1998-02-17 2002-03-19 Conticare Medical, Inc. Urinary drain
US6293967B1 (en) 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US20020051730A1 (en) * 2000-09-29 2002-05-02 Stanko Bodnar Coated medical devices and sterilization thereof
US7261735B2 (en) * 2001-05-07 2007-08-28 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
US20020111590A1 (en) * 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
US8303609B2 (en) 2000-09-29 2012-11-06 Cordis Corporation Coated medical devices
US6500149B2 (en) 1998-08-31 2002-12-31 Deepak Gandhi Apparatus for deployment of micro-coil using a catheter
US6358276B1 (en) * 1998-09-30 2002-03-19 Impra, Inc. Fluid containing endoluminal stent
US6375648B1 (en) * 1998-10-02 2002-04-23 Misonix Incorporated Infiltration cannula with teflon coated outer surface
US6048332A (en) * 1998-10-09 2000-04-11 Ave Connaught Dimpled porous infusion balloon
US6214042B1 (en) * 1998-11-10 2001-04-10 Precision Vascular Systems, Inc. Micro-machined stent for vessels, body ducts and the like
US6258118B1 (en) 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
US6413273B1 (en) 1998-11-25 2002-07-02 Israel Aircraft Industries Ltd. Method and system for temporarily supporting a tubular organ
US6348067B1 (en) * 1998-11-25 2002-02-19 Israel Aircraft Industries Ltd. Method and system with shape memory heating apparatus for temporarily supporting a tubular organ
US6478773B1 (en) * 1998-12-21 2002-11-12 Micrus Corporation Apparatus for deployment of micro-coil using a catheter
US6835185B2 (en) 1998-12-21 2004-12-28 Micrus Corporation Intravascular device deployment mechanism incorporating mechanical detachment
US7740637B2 (en) 2000-02-09 2010-06-22 Micrus Endovascular Corporation Apparatus and method for deployment of a therapeutic device using a catheter
US6296622B1 (en) 1998-12-21 2001-10-02 Micrus Corporation Endoluminal device delivery system using axially recovering shape memory material
JP3524788B2 (en) 1998-12-24 2004-05-10 株式会社パイオラックス Indwelling catheter for the anticancer agent administration
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
US6398758B1 (en) 1999-02-16 2002-06-04 Stephen C. Jacobsen Medicament delivery system
US20010041870A1 (en) * 1999-03-09 2001-11-15 Edward M. Gillis Implantable device for access to a treatment site
US6702811B2 (en) 1999-04-05 2004-03-09 Medtronic, Inc. Ablation catheter assembly with radially decreasing helix and method of use
US6514236B1 (en) 1999-04-23 2003-02-04 Alexander A. Stratienko Method for treating a cardiovascular condition
US6245045B1 (en) 1999-04-23 2001-06-12 Alexander Andrew Stratienko Combination sheath and catheter for cardiovascular use
US6595959B1 (en) 1999-04-23 2003-07-22 Alexander A. Stratienko Cardiovascular sheath/catheter
US6156373A (en) * 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
US6290673B1 (en) * 1999-05-20 2001-09-18 Conor Medsystems, Inc. Expandable medical device delivery system and method
US6478778B1 (en) * 1999-05-28 2002-11-12 Precision Vascular Systems, Inc. Apparatus for delivering fluids to blood vessels, body cavities, and the like
JP3272716B2 (en) * 1999-06-16 2002-04-08 株式会社メディテック catheter
US6368315B1 (en) 1999-06-23 2002-04-09 Durect Corporation Composite drug delivery catheter
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
US6283947B1 (en) 1999-07-13 2001-09-04 Advanced Cardiovascular Systems, Inc. Local drug delivery injection catheter
US6494862B1 (en) 1999-07-13 2002-12-17 Advanced Cardiovascular Systems, Inc. Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway
US6350253B1 (en) 1999-07-19 2002-02-26 I-Flow Corporation Catheter for uniform delivery of medication
US7510550B2 (en) * 1999-07-19 2009-03-31 I-Flow Corporation Catheter for uniform delivery of medication
US7452353B2 (en) * 1999-07-19 2008-11-18 I-Flow Corporation Catheter for uniform delivery of medication
US7547302B2 (en) * 1999-07-19 2009-06-16 I-Flow Corporation Anti-microbial catheter
US7004923B2 (en) * 1999-07-19 2006-02-28 I-Flow Corporation Catheter for uniform delivery of medication
WO2001013986A1 (en) * 1999-08-25 2001-03-01 Georgetown University Delivery system for therapy comprising hollow seeds, preferably metal, and use thereof
AU7839900A (en) 1999-09-29 2001-04-30 Sterling Medivations, Inc. Reusable medication delivery device
US6596235B2 (en) 1999-09-30 2003-07-22 Therox, Inc. Method for blood oxygenation
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
CA2391488C (en) 1999-11-22 2012-04-03 Boston Scientific Limited Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7670327B2 (en) * 2000-01-20 2010-03-02 Regents Of The University Of Minnesota Catheter systems for delivery of agents and related method thereof
US6663613B1 (en) * 2000-01-25 2003-12-16 Bacchus Vascular, Inc. System and methods for clot dissolution
US6929633B2 (en) 2000-01-25 2005-08-16 Bacchus Vascular, Inc. Apparatus and methods for clot dissolution
US6379382B1 (en) 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6613082B2 (en) 2000-03-13 2003-09-02 Jun Yang Stent having cover with drug delivery capability
US7805188B2 (en) * 2000-03-24 2010-09-28 Micor, Inc. Anesthesia conduction catheter for delivery of electrical stimulus
EP1267983B1 (en) * 2000-03-24 2006-07-26 Stephen Brushey Anesthesia conduction catheter
US8101200B2 (en) * 2000-04-13 2012-01-24 Angiotech Biocoatings, Inc. Targeted therapeutic agent release devices and methods of making and using the same
US20040243097A1 (en) * 2000-05-12 2004-12-02 Robert Falotico Antiproliferative drug and delivery device
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
AT525977T (en) * 2000-06-05 2011-10-15 Boston Scient Ltd Intravascular stent with improved stamina of a coating
US6685672B1 (en) * 2000-07-13 2004-02-03 Edwards Lifesciences Corporation Multi-balloon drug delivery catheter for angiogenesis
US7108701B2 (en) * 2001-09-28 2006-09-19 Ethicon, Inc. Drug releasing anastomosis devices and methods for treating anastomotic sites
US20030065377A1 (en) * 2001-09-28 2003-04-03 Davila Luis A. Coated medical devices
US20030065345A1 (en) * 2001-09-28 2003-04-03 Kevin Weadock Anastomosis devices and methods for treating anastomotic sites
US7195640B2 (en) * 2001-09-25 2007-03-27 Cordis Corporation Coated medical devices for the treatment of vulnerable plaque
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
WO2002032347A2 (en) 2000-10-16 2002-04-25 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6764507B2 (en) 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
US7208011B2 (en) 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
US6692458B2 (en) 2000-12-19 2004-02-17 Edwards Lifesciences Corporation Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis
US6964680B2 (en) * 2001-02-05 2005-11-15 Conor Medsystems, Inc. Expandable medical device with tapered hinge
US7771468B2 (en) * 2001-03-16 2010-08-10 Angiotech Biocoatings Corp. Medicated stent having multi-layer polymer coating
US6719804B2 (en) 2001-04-02 2004-04-13 Scimed Life Systems, Inc. Medical stent and related methods
DE10131152B4 (en) * 2001-04-30 2004-05-27 Nutricia Healthcare S.A. Medical balloon-button system
US7122027B2 (en) * 2001-05-25 2006-10-17 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US6629969B2 (en) * 2001-07-26 2003-10-07 Durect Corporation Catheter for modification of agent formulation
US7364565B2 (en) 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
US6620202B2 (en) * 2001-10-16 2003-09-16 Scimed Life Systems, Inc. Medical stent with variable coil and related methods
CA2463724A1 (en) * 2001-10-16 2003-04-24 Jing Wang Organosulfur inhibitors of tyrosine phosphatases
US6936040B2 (en) * 2001-10-29 2005-08-30 Medtronic, Inc. Method and apparatus for endovenous pacing lead
US8916598B2 (en) 2003-05-30 2014-12-23 Proteotech Inc Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
US7438710B2 (en) * 2001-11-07 2008-10-21 Anderson Kent D Distal protection device with local drug infusion by physician to maintain patency
US7041139B2 (en) 2001-12-11 2006-05-09 Boston Scientific Scimed, Inc. Ureteral stents and related methods
EP1480658B1 (en) * 2002-02-13 2017-01-25 Beth Israel Deaconess Medical Center, Inc. Methods of treating vascular disease
US8506647B2 (en) * 2002-02-14 2013-08-13 Boston Scientific Scimed, Inc. System for maintaining body canal patency
US8328877B2 (en) 2002-03-19 2012-12-11 Boston Scientific Scimed, Inc. Stent retention element and related methods
US20030191453A1 (en) * 2002-04-03 2003-10-09 Velez Omar E. Catheter assembly
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
JP2005522521A (en) 2002-04-15 2005-07-28 ベス イスラエル デアコネス メディカル センター Using heme oxygenase-1 and heme degradation products
US7122048B2 (en) * 2002-05-03 2006-10-17 Scimed Life Systems, Inc. Hypotube endoluminal device
CN1674942A (en) * 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
CA2490692A1 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
EP1606291A2 (en) * 2002-07-02 2005-12-21 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its dervatives
AT495769T (en) * 2002-07-12 2011-02-15 Cook Inc Coated medical device
JP3887588B2 (en) * 2002-08-30 2007-02-28 株式会社リガク Stress measurement method using X-ray diffraction
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20040127976A1 (en) * 2002-09-20 2004-07-01 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20040059228A1 (en) * 2002-09-23 2004-03-25 Scimed Life Systems, Inc. Systems and methods for flushing catheters
AU2003290806A1 (en) * 2002-11-15 2004-06-15 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Variable curve catheter
WO2004087214A1 (en) 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device with beneficial agent concentration gradient
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
US20040248877A1 (en) * 2003-04-30 2004-12-09 Sandeep Gupta Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof
WO2004099158A1 (en) * 2003-04-30 2004-11-18 Ricerca Biosciences, Llc. Monocyclic diazodioxide based bcl-2 protein antagonists
WO2004098565A2 (en) * 2003-05-02 2004-11-18 Surmodics, Inc. Implantable controlled release bioactive agent delivery device
MXPA05012281A (en) * 2003-05-14 2006-05-19 Torreypines Therapeutics Inc Compouds and uses thereof in modulating amyloid beta.
US20040249364A1 (en) * 2003-06-03 2004-12-09 Ilya Kaploun Device and method for dispensing medication to tissue lining a body cavity
US7169179B2 (en) * 2003-06-05 2007-01-30 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery
US20040260271A1 (en) * 2003-06-18 2004-12-23 Huyser Richard F. Extended fenestration catheter with internal coil and method of making the same
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
US20050101938A1 (en) * 2003-11-06 2005-05-12 Leiboff Arnold R. Guidewire for use in colonic irrigation
WO2005090370A1 (en) 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
WO2005113523A1 (en) 2004-05-20 2005-12-01 Foldrx Pharmaceuticals, Inc. 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
WO2005122959A2 (en) 2004-06-08 2005-12-29 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
WO2006009876A2 (en) * 2004-06-17 2006-01-26 Cengent Therapeutics, Inc. Trisubstituted nitrogen modulators of tyrosine phosphatases
EP1786421A2 (en) * 2004-07-09 2007-05-23 Cengent Therapeutics, Inc. Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
FR2873016B1 (en) * 2004-07-15 2006-09-29 Pierre Marcel Bourgogne Prostheses Artificial vascular constantly delivering actives preventing any stenosis, thrombosis, cell proliferation, etc. .. permanent ease access for any intervention
JP2008510726A (en) * 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド Compositions and methods comprising proteinase activated receptor antagonist
WO2006028970A1 (en) 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
CN102379872A (en) 2004-09-17 2012-03-21 弗尔德里克斯制药股份有限公司 Compounds, compositions and methods of inhibiting a-synuclein toxicity
US20060067889A1 (en) * 2004-09-27 2006-03-30 Light Sciences Corporation Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
US20080140187A1 (en) * 2004-10-15 2008-06-12 Krause Arthur A Anti-clotting, anti-microbial, anti-inflammatory medical stent
US8983582B2 (en) * 2004-12-20 2015-03-17 Advanced Cardiovascular Systems, Inc. Methods and apparatuses for positioning within an internal channel
US20090156545A1 (en) * 2005-04-01 2009-06-18 Hostetler Karl Y Substituted Phosphate Esters of Nucleoside Phosphonates
AT534652T (en) 2005-04-01 2011-12-15 Univ California Phosphono-pent-2-en-1-yl-nucleoside analogues and
US20060229573A1 (en) * 2005-04-08 2006-10-12 Mckinley Medical L.L.L.P. Adjustable infusion catheter
US20120149985A1 (en) * 2007-05-18 2012-06-14 Frassica James J Rotate-to-advance catheterization system
US8870755B2 (en) 2007-05-18 2014-10-28 Olympus Endo Technology America Inc. Rotate-to-advance catheterization system
US7396366B2 (en) 2005-05-11 2008-07-08 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
US20100098640A1 (en) * 2005-06-20 2010-04-22 Cohen Seth M Multidentate Pyrone-Derived Chelators for Medicinal Imaging and Chelation
WO2007000159A1 (en) * 2005-06-27 2007-01-04 William Cook Europe Aps A dilator for performing a percutaneous medical procedure
US9101949B2 (en) * 2005-08-04 2015-08-11 Eilaz Babaev Ultrasonic atomization and/or seperation system
US20070031611A1 (en) * 2005-08-04 2007-02-08 Babaev Eilaz P Ultrasound medical stent coating method and device
JP5265359B2 (en) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー Intravesical drug delivery device and method
US7896539B2 (en) * 2005-08-16 2011-03-01 Bacoustics, Llc Ultrasound apparatus and methods for mixing liquids and coating stents
US8492428B2 (en) * 2005-09-20 2013-07-23 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
US7540881B2 (en) * 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
WO2007076160A2 (en) * 2005-12-28 2007-07-05 Acidophil Llc C-10 carbamates of taxanes
MX2008011633A (en) * 2006-03-13 2008-12-16 Activx Biosciences Inc Aminoquinolones as gsk-3 inhibitors.
AU2007245129A1 (en) * 2006-03-29 2007-11-08 Foldrx Pharmaceuticals, Inc. Inhibition of alpha-synuclein toxicity
EP2015841A4 (en) * 2006-04-27 2010-06-23 St Jude Medical Implantable medical device with releasing compound
TW201343676A (en) 2006-08-28 2013-11-01 Kyowa Hakko Kirin Co Ltd Antagonistic human light-specific human monoclonal antibodies
US7547323B2 (en) * 2006-08-29 2009-06-16 Sinexus, Inc. Stent for irrigation and delivery of medication
ZA200902091B (en) 2006-09-21 2010-07-28 Activx Biosciences Inc Serine hydrolase inhibitors
US20080082083A1 (en) * 2006-09-28 2008-04-03 Forde Sean T Perforated expandable implant recovery sheath
US20090264421A1 (en) * 2007-10-05 2009-10-22 Bible Keith C Methods and Compositions for Treating Cancer
US7951191B2 (en) * 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US20080140176A1 (en) * 2006-10-18 2008-06-12 Krause Arthur A Medical stent and devices for localized treatment of disease
AU2007310949A1 (en) 2006-10-19 2008-04-24 Auspex Pharmaceuticals, Inc. Substituted indoles
US8287519B2 (en) * 2006-10-27 2012-10-16 Smith Tech Innovations, Llc Self-cleansing bladder drainage catheter
WO2008057604A2 (en) * 2006-11-08 2008-05-15 The Regents Of The University Of California Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
US7842082B2 (en) * 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20080140008A1 (en) * 2006-12-06 2008-06-12 Medtronic, Inc. Intrathecal catheter
US20080142616A1 (en) * 2006-12-15 2008-06-19 Bacoustics Llc Method of Producing a Directed Spray
WO2008077103A1 (en) 2006-12-19 2008-06-26 Auspex Pharmaceuticals, Inc. Preperation and utility of ccr5 inhibitors
MX2009006812A (en) * 2006-12-22 2009-07-02 Encysive Pharmaceuticals Inc Modulators of c3a receptor and methods of use thereof.
WO2008106167A1 (en) * 2007-02-28 2008-09-04 Conatus Pharmaceuticals, Inc. Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
JP2010520200A (en) * 2007-02-28 2010-06-10 クオナトウス ファーマシューティカルズ,インコーポレイテッド Method of treating liver disease using certain matrix metalloproteinase (mmp) inhibitors
WO2008140859A1 (en) 2007-03-15 2008-11-20 Auspex Pharmaceuticals, Inc. Deuterated venlafaxines and 0-desmetylvenlafaxines with serotoninergic and / or norepinephrinergic activity
AU2008227875B2 (en) 2007-03-19 2014-06-12 Insuline Medical Ltd. Drug delivery device
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US8398576B2 (en) 2007-04-02 2013-03-19 University of Pittsburgh—of the Commonwealth System of Higher Education Removal of contrast agents from blood
US7892776B2 (en) 2007-05-04 2011-02-22 The Regents Of The University Of California Screening assay to identify modulators of protein kinase A
US20080281291A1 (en) * 2007-05-07 2008-11-13 Claude Tihon Drainage/irrigation urethral catheter
US8721711B2 (en) * 2007-06-20 2014-05-13 Oregon Health & Science University Graft having microporous membrane for uniform fluid infusion
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド The self-expanding prosthesis
US9402973B2 (en) 2007-07-06 2016-08-02 Vital 5, Llc Constrained fluid delivery device
BRPI0814542A2 (en) * 2007-07-12 2014-09-30 Tragara Pharmaceuticals Inc Methods and compositions for the treatment of cancer, tumors and tumor-related disorders
US7780095B2 (en) 2007-07-13 2010-08-24 Bacoustics, Llc Ultrasound pumping apparatus
US7753285B2 (en) 2007-07-13 2010-07-13 Bacoustics, Llc Echoing ultrasound atomization and/or mixing system
BRPI0816798A2 (en) * 2007-09-11 2016-10-11 Activx Biosciences Inc compound, pharmaceutical composition, methods for inhibiting glycogen synthase kinase action-3, and for treating, preventing or ameliorating a disease, the use of a compound, and article of manufacture
EP2203459B1 (en) 2007-09-12 2016-03-16 Kyorin Pharmaceutical Co., Ltd. Spirocyclic aminoquinolones as gsk-3 inhibitors
US7959669B2 (en) * 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US8100855B2 (en) 2007-09-17 2012-01-24 Abbott Cardiovascular Systems, Inc. Methods and devices for eluting agents to a vessel
US20090076591A1 (en) * 2007-09-19 2009-03-19 Boston Scientific Scimed, Inc. Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
EP2205226A2 (en) * 2007-10-09 2010-07-14 Université René Descartes - Paris 5 Device for administering cells and cell-therapy methods using said device
US8829198B2 (en) * 2007-10-31 2014-09-09 Proteotech Inc Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
WO2009066152A2 (en) 2007-11-21 2009-05-28 Pharmaxis Ltd. Haloallylamine inhibitors of ssao/vap-1 and uses therefor
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
NZ585449A (en) * 2007-12-11 2012-07-27 Massachusetts Inst Technology Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens
WO2009079388A2 (en) * 2007-12-14 2009-06-25 Oregon Health & Science University Drug delivery cuff
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US8277501B2 (en) * 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US8196279B2 (en) 2008-02-27 2012-06-12 C. R. Bard, Inc. Stent-graft covering process
WO2009111611A2 (en) * 2008-03-05 2009-09-11 Proteotech Inc. Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
ES2610989T3 (en) 2008-03-17 2017-05-04 Ambit Biosciences Corporation 1- (3- (6,7-dimethoxyquinazolin-4-yloxy) phenyl) -3- (5- (1,1,1-trifluoro-2-methylpropane-2-ol) isoxazol-3-yl) urea as a modulator RAF kinases in the treatment of cancer diseases
US20090240318A1 (en) * 2008-03-19 2009-09-24 Boston Scientific Scimed, Inc. Stent expansion column, strut and connector slit design
US20090275918A1 (en) * 2008-05-01 2009-11-05 Stemcor Systems, Inc. Pancreatic delivery catheter
US8932340B2 (en) * 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
AU2009256168B2 (en) 2008-06-04 2014-06-05 Grifols Therapeutics Inc. Composition, method and kit for preparing plasmin
EA201170297A1 (en) * 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи An implantable device for delivering drugs and method of treating male urinary and surrounding tissues
US20120034155A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
CN101658533A (en) * 2008-08-29 2010-03-03 首都医科大学宣武医院 Delivery of stem cells of antitumor medicament
WO2010030728A2 (en) * 2008-09-12 2010-03-18 Boston Scientific Scimed, Inc. Devices and systems for delivery of therapeutic agents to body lumens
WO2010036541A1 (en) * 2008-09-24 2010-04-01 Cook Incorporated Catheter system having variable stiffness
ES2436788T3 (en) * 2008-10-09 2014-01-07 Nyxx Technologies Limited Medical device
WO2010059364A2 (en) * 2008-10-30 2010-05-27 Epitek, Inc. Method and apparatus for sub-xiphoid delivery of therapeutic agents
MX2011004817A (en) 2008-11-07 2011-07-28 Insuline Medical Ltd Device and method for drug delivery.
WO2010088450A2 (en) 2009-01-30 2010-08-05 Celladon Corporation Methods for treating diseases associated with the modulation of serca
PT2401267E (en) 2009-02-27 2014-04-10 Ambit Biosciences Corp Jak kinase modulating quinazoline derivatives and their use in methods
US9206410B2 (en) 2009-03-03 2015-12-08 Grifols Therapeutics Inc. Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom
JP5690286B2 (en) 2009-03-04 2015-03-25 イデニク プハルマセウティカルス,インコーポレイテッド Phosphonate thiophene and Hosuhochiazoru hcv polymerase inhibitors
WO2010105016A1 (en) 2009-03-11 2010-09-16 Ambit Biosciences Corp. Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
WO2010104205A1 (en) * 2009-03-11 2010-09-16 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminoquinolones as gsk-3 inhibitors
WO2010110686A1 (en) 2009-03-27 2010-09-30 Pathway Therapeutics Limited Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
TW201038567A (en) 2009-03-27 2010-11-01 Pathway Therapeutics Ltd Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
WO2010123960A2 (en) 2009-04-22 2010-10-28 Axikin Pharmaceuticals, Inc. Arylsulfonamide ccr3 antagonists
EP2421830B1 (en) 2009-04-22 2014-04-02 Axikin Pharmaceuticals, Inc. 2,5-disubstituted arylsulfonamide ccr3 antagonists
AR078120A1 (en) 2009-04-22 2011-10-19 Axikin Pharmaceuticals Inc CCR3 antagonists arylsulfonamide 2,5-disubstituted and pharmaceutical compositions
US8945202B2 (en) 2009-04-28 2015-02-03 Endologix, Inc. Fenestrated prosthesis
US20100292641A1 (en) * 2009-05-15 2010-11-18 Bandula Wijay Targeted drug delivery device and method
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US20100331770A1 (en) 2009-06-26 2010-12-30 Taris Biomedical, Inc. Implantable Drug Delivery Devices and Methods of Making the Same
WO2011003870A2 (en) 2009-07-06 2011-01-13 Creabilis S.A. Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
DK3072890T3 (en) 2009-07-07 2019-02-11 Mei Pharma Inc Pyrimidinyl and 1,3,5-triazinylbenzimidazoler and their use in cancer therapy
DK2451435T3 (en) 2009-07-08 2018-01-15 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Sodium thiosulfate-containing pharmaceutical compositions
US20110022026A1 (en) * 2009-07-21 2011-01-27 Lake Region Manufacturing, Inc. d/b/a Lake Region Medical. Inc. Methods and Devices for Delivering Drugs Using Drug-Delivery or Drug-Coated Guidewires
US8404728B2 (en) 2009-07-30 2013-03-26 Mayo Foundation For Medical Education And Research Small-molecule botulinum toxin inhibitors
EP2461811B1 (en) 2009-08-05 2016-04-20 Idenix Pharmaceuticals LLC. Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
KR20120059558A (en) 2009-08-19 2012-06-08 암비트 바이오사이언시즈 코포레이션 Biaryl compounds and methods of use thereof
WO2011056566A2 (en) 2009-10-26 2011-05-12 Sunesis Pharmaceuticals, Inc. Compounds and methods for treatment of cancer
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
EP2499282B1 (en) 2009-11-09 2015-04-22 NeuroGenetic Pharmaceuticals, Inc. Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
WO2011069002A1 (en) 2009-12-02 2011-06-09 Alquest Therapeutics, Inc. Organoselenium compounds and uses thereof
CN102822175A (en) 2009-12-18 2012-12-12 埃迪尼克斯医药公司 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
WO2011079313A1 (en) * 2009-12-23 2011-06-30 Map Pharmaceuticals, Inc. Novel ergoline analogs
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
EP2542542B1 (en) 2010-03-02 2015-04-22 Axikin Pharmaceuticals, Inc. Isotopically enriched arylsulfonamide ccr3 antagonists
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
TW201134820A (en) 2010-03-17 2011-10-16 Axikin Pharmaceuticals Inc Arylsulfonamide CCR3 antagonists
WO2011140186A1 (en) 2010-05-05 2011-11-10 Cook Medical Technologies Llc Treatment fluid delivery method, and turbulator for promoting uptake of a treatment agent
EP2566558A1 (en) * 2010-05-05 2013-03-13 Cook Medical Technologies LLC Intraluminal treatment apparatus, wire guide and treatment fluid delivery method
WO2011150198A1 (en) 2010-05-27 2011-12-01 Ambit Biosciences Corporation Azolyl urea compounds and methods of use thereof
WO2011150201A2 (en) 2010-05-27 2011-12-01 Ambit Biosciences Corporation Azolyl amide compounds and methods of use thereof
AU2011261499B2 (en) 2010-06-01 2015-07-16 Biotheryx, Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
JP6019015B2 (en) 2010-06-01 2016-11-02 ビオトヘルイク, インコーポレイテッド 6-cyclohexyl-1-hydroxy-4-methyl -2 (1h) - a method of treatment of hematologic malignancies that uses pyridone
CN103108868B (en) 2010-06-07 2015-11-25 诺沃梅迪科斯有限公司 Furanyl compounds and their use
JP6069661B2 (en) 2010-06-24 2017-02-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Compositions and their use in the regulation of various amyloid β peptide allo form level
EP2595615A1 (en) 2010-07-19 2013-05-29 Summa Health System Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease
US20120053176A1 (en) 2010-09-01 2012-03-01 Ambit Biosciences Corp. Adenosine a3 receptor modulating compounds and methods of use thereof
MX2013002383A (en) 2010-09-01 2013-07-05 Ambit Biosciences Corp Hydrobromide salts of a pyrazolylaminoquinazoline.
JP5932794B2 (en) 2010-09-01 2016-06-08 アムビト ビオスシエンセス コルポラチオン Pyrazolyl quinazoline and pharmaceutical compositions thereof and methods of using an optically active
EP2611809A1 (en) 2010-09-01 2013-07-10 Ambit Biosciences Corporation Azolopyridine and azolopyrimidine compounds and methods of use thereof
US20130225614A1 (en) 2010-09-01 2013-08-29 Ambit Biosciences Corporation 4-azolylaminoquinazoline derivatives and methods of use thereof
WO2012030894A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Thienopyridine and thienopyrimidine compounds and methods of use thereof
WO2012030944A2 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Quinoline and isoquinoline compounds and methods of use thereof
WO2012030912A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation 7-cyclylquinazoline derivatives and methods of use thereof
CN103298805A (en) 2010-09-01 2013-09-11 埃姆比特生物科学公司 Quinazoline compounds and methods of use thereof
WO2012030910A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation 2-cycloquinazoline derivatives and methods of use thereof
US9265913B2 (en) 2010-09-22 2016-02-23 Vital 5, Llc Catheter assembly
US9446224B2 (en) 2010-09-22 2016-09-20 Vital 5, L.L.C. Barrier catheter
USD679804S1 (en) 2011-09-22 2013-04-09 Vital 5, Llc Catheter
WO2012044641A1 (en) 2010-09-29 2012-04-05 Pathway Therapeutics Inc. 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
IT1402059B1 (en) * 2010-09-29 2013-08-28 Rand Srl wearable system to perform purifying therapies of organic fluids with the use of extracorporeal circuits
WO2012051090A1 (en) 2010-10-11 2012-04-19 Axikin Pharmaceuticals, Inc. Salts of arylsulfonamide ccr3 antagonists
US9084610B2 (en) 2010-10-21 2015-07-21 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses, systems, and methods for renal neuromodulation
WO2012061161A1 (en) 2010-10-25 2012-05-10 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
EP2648676A4 (en) 2010-12-06 2016-05-04 Follica Inc Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
SG191893A1 (en) 2011-01-10 2013-08-30 Taris Biomedical Inc Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
AR085091A1 (en) 2011-01-26 2013-09-11 Kolltan Pharmaceuticals Inc anti-kit antibodies and their uses
US10052459B2 (en) * 2011-01-28 2018-08-21 Cook Medical Technologies Llc Catheter assembly and method
CN103338753A (en) 2011-01-31 2013-10-02 细胞基因公司 Pharmaceutical compositions of cytidine analogs and methods of use thereof
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
WO2012109398A1 (en) 2011-02-10 2012-08-16 Idenix Pharmaceuticals, Inc. Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
US20140088102A1 (en) 2011-03-28 2014-03-27 Mei Pharma, Inc. (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
RU2608742C2 (en) 2011-03-28 2017-01-23 ЭмИАй ФАРМА, ИНК. (alpha-substituted aralkylamino- and heteroarylalkylamino)pyrimidinyl- and 1,3,5-triazinylbenzimidazoles, pharmaceutical compositions thereof and use thereof in treating proliferative diseases
US20140088103A1 (en) 2011-03-28 2014-03-27 Mei Pharma, Inc. (fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
JP2014517723A (en) * 2011-04-05 2014-07-24 ファルマセンス アクチェンゲゼルシャフト Venous access for transdermal mounting device
EP2694150A1 (en) 2011-04-08 2014-02-12 Covidien LP Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
EP2688489B1 (en) * 2011-04-20 2017-09-20 Kinamed, Inc. Shapeable passer for surgical cable or suture
KR20140042868A (en) 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 Novel fluoroergoline analogs
WO2013022005A1 (en) * 2011-08-08 2013-02-14 オリンパスメディカルシステムズ株式会社 Treatment tool
WO2013037482A1 (en) 2011-09-15 2013-03-21 Phenex Pharmaceuticals Ag Farnesoid x receptor agonists for cancer treatment and prevention
US20130085468A1 (en) * 2011-10-03 2013-04-04 Yuri Buydenok Catheter with body wall separator
TW201811777A (en) 2011-10-14 2018-04-01 Ambit Biosciences Corp Heterocyclic compounds and methods of use thereof
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
EP2793583A4 (en) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc Novel neuromodulatory compounds
WO2013130600A1 (en) 2012-02-29 2013-09-06 Ambit Biosciences Corporation Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
NZ628084A (en) 2012-03-16 2016-09-30 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
AU2013235386B2 (en) * 2012-03-19 2016-12-08 Cook Medical Technologies Llc Medical devices, methods and kits for delivering medication to a bodily passage
AU2013255103B2 (en) 2012-05-02 2016-09-29 Boehringer Ingelheim International Gmbh Substituted 3-haloallylamine inhibitors of SSAO and uses thereof
RU2601906C2 (en) 2012-05-11 2016-11-10 Медтроник АФ Люксембург С.а.р.л. Catheter device containing blocks of several electrodes for renal neuromodulation and appropriate systems and methods
EP3406598A1 (en) 2012-06-14 2018-11-28 Mayo Foundation for Medical Education and Research Pyrazole derivatives as inhibitors of stat3
US9381326B2 (en) * 2012-06-15 2016-07-05 W. L. Gore & Associates, Inc. Vascular occlusion and drug delivery devices, systems, and methods
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
DK2877493T3 (en) 2012-07-25 2018-06-14 Celldex Therapeutics Inc Anti-kit antibodies and uses thereof
EP2892884A1 (en) 2012-09-07 2015-07-15 Axikin Pharmaceuticals, Inc. Isotopically enriched arylsulfonamide ccr3 antagonists
WO2014055647A1 (en) 2012-10-03 2014-04-10 Mei Pharma, Inc. (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
US9044575B2 (en) 2012-10-22 2015-06-02 Medtronic Adrian Luxembourg S.a.r.l. Catheters with enhanced flexibility and associated devices, systems, and methods
WO2014074765A2 (en) 2012-11-08 2014-05-15 Summa Health System Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
MX2015006544A (en) 2012-11-30 2015-09-24 Novomedix Llc Substituted biaryl sulfonamides and the use thereof.
US9409003B2 (en) 2012-12-07 2016-08-09 Cook Medical Technologies, LLC System for reducing local discomfort
SG11201504931SA (en) 2012-12-21 2015-07-30 Map Pharmaceuticals Inc Novel methysergide derivatives
US9169214B2 (en) 2012-12-21 2015-10-27 The Board Of Trustees Of The Leland Stanford Junior University Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
EP2943188A1 (en) 2013-01-11 2015-11-18 Mayo Foundation for Medical Education and Research Vitamins c and k for treating polycystic diseases
WO2014126870A1 (en) * 2013-02-12 2014-08-21 Gary Keeling Body cavity drainage device and methods for using the same
WO2014165263A1 (en) 2013-03-12 2014-10-09 The Regents Of The University Of California, A California Corporation Gamma-secretase modulators
US9179974B2 (en) 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US10100123B2 (en) 2013-06-06 2018-10-16 Pierre Fabre Medicament Anti-C10orf54 antibodies and uses thereof
WO2015031613A1 (en) 2013-08-30 2015-03-05 Ambit Biosciences Corporation Biaryl acetamide compounds and methods of use thereof
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
WO2015042375A1 (en) 2013-09-20 2015-03-26 Idenix Pharmaceuticals, Inc. Hepatitis c virus inhibitors
US20150112302A1 (en) * 2013-10-22 2015-04-23 Medtronic Minimed, Inc. Methods and systems for inhibiting foreign-body responses in diabetic patients
WO2015113034A1 (en) 2014-01-27 2015-07-30 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods
AU2016227493A1 (en) 2015-03-03 2017-06-08 Kymab Limited Antibodies, uses & methods
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
JP2017508816A (en) 2014-03-20 2017-03-30 カペラ セラピューティクス,インコーポレーテッド Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
JP2017515854A (en) 2014-05-12 2017-06-15 クオナトウス ファーマシューティカルズ,インコーポレイテッド Treatment of complications of chronic liver disease by caspase inhibitors
WO2015184099A1 (en) 2014-05-28 2015-12-03 4-Antibody Ag Anti-gitr antibodies and methods of use thereof
WO2015195474A1 (en) 2014-06-18 2015-12-23 Biotheryx, Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
US9499514B2 (en) 2014-07-11 2016-11-22 Celgene Corporation Antiproliferative compounds and methods of use thereof
EP3179857A4 (en) 2014-08-14 2018-04-11 Alhamadsheh, Mamoun, M. Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
US20170354639A1 (en) 2014-10-24 2017-12-14 Biogen Ma Inc. Diterpenoid derivatives and methods of use thereof
AR103264A1 (en) 2014-12-23 2017-04-26 Axikin Pharmaceuticals Inc 3,5-aminopyrazole derivatives as kinase inhibitors rc
CA2974113A1 (en) 2015-01-20 2016-07-28 Xoc Pharmaceuticals, Inc. Isoergoline compounds and uses thereof
JP2018502888A (en) 2015-01-20 2018-02-01 エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc Ergoline compounds and their use
MX2017015046A (en) 2015-05-29 2018-05-17 Agenus Inc Anti-ctla-4 antibodies and methods of use thereof.
WO2016210180A2 (en) 2015-06-23 2016-12-29 Neurocrine Biosciences, Inc. Vmat2 inhibitors for treating neurological diseases or disorders
US20180264226A1 (en) * 2015-07-20 2018-09-20 Strataca Systems, LLC Catheter Device and Method for Inducing Negative Pressure in a Patient's Bladder
CN107949573A (en) 2015-09-01 2018-04-20 艾吉纳斯公司 Anti-PD-1 antibodies and methods of use thereof
MX2018005136A (en) 2015-10-30 2018-05-07 Neurocrine Biosciences Inc Valbenazine salts and polymorphs thereof.
WO2017079566A1 (en) 2015-11-05 2017-05-11 Conatus Pharmaceuticals, Inc. Caspase inhibitors for use in the treatment of liver cancer
US10112924B2 (en) 2015-12-02 2018-10-30 Astraea Therapeutics, Inc. Piperdinyl nociceptin receptor compounds
BR112018013558A2 (en) 2015-12-31 2018-12-04 Conatus Pharmaceuticals Inc method of treatment of a liver disease in an individual, method of use of a caspase inhibitor, a method to reduce or sustain a meld classification or its components, method of treating, reducing or sustain a meld classification or its components, method of treating, reduce or sustain a Child-Pugh score or components thereof, pharmaceutical composition comprising a caspase inhibitor, kit, method of treatment of liver cirrhosis method of treatment and prevention of high meld classification method of treatment of liver cirrhosis and prevention a high Child-Pugh classification
AU2017206039A1 (en) 2016-01-08 2018-07-19 Celgene Corporation Solid forms of 2-(4-chlorophenyl)-N-((2-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
SG11201805779TA (en) 2016-01-08 2018-08-30 Celgene Corp Antiproliferative compounds, and their pharmaceutical compositions and uses
US10064855B2 (en) 2016-03-08 2018-09-04 Los Gatos Pharmaceuticals, Inc. Composite nanoparticles and uses thereof
EP3442940A1 (en) 2016-04-11 2019-02-20 Clexio Biosciences Ltd. Deuterated ketamine derivatives
WO2017180794A1 (en) 2016-04-13 2017-10-19 Skyline Antiinfectives, Inc. Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams
WO2017194789A1 (en) 2016-05-13 2017-11-16 Institut Pasteur Inhibition of beta-2 nicotinic acetylcholine receptors to treat alzheimer's disease pathology
TW201805271A (en) 2016-05-16 2018-02-16 Biotheryx Inc Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated disease
US20170368168A1 (en) 2016-05-27 2017-12-28 Agenus Inc. Anti-tim-3 antibodies and methods of use thereof
CA3030099A1 (en) 2016-07-08 2018-01-11 Staten Biotechnology B.V. Anti-apoc3 antibodies and methods of use thereof
TW201825517A (en) 2016-10-11 2018-07-16 美商艾吉納斯公司 Anti-lag-3 antibodies and methods of use
WO2018083248A1 (en) 2016-11-03 2018-05-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
WO2018089692A1 (en) 2016-11-09 2018-05-17 Phloronol, Inc. Eckol derivatives, methods of synthesis and uses thereof
WO2018089427A1 (en) 2016-11-09 2018-05-17 Novomedix, Llc Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
WO2018102673A1 (en) 2016-12-02 2018-06-07 Neurocrine Biosciences, Inc. Use of valbenazine for treating schizophrenia or schizoaffective disorder
WO2018164996A1 (en) 2017-03-06 2018-09-13 Neurocrine Biosciences, Inc. Dosing regimen for valbenazine
WO2018183182A1 (en) 2017-03-27 2018-10-04 Celgene Corporation Methods and compositions for reduction of immunogenicity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693243A (en) * 1983-01-14 1987-09-15 Buras Sharon Y Conduit system for directly administering topical anaesthesia to blocked laryngeal-tracheal areas
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
NZ228382A (en) * 1989-03-17 1992-08-26 Carter Holt Harvey Plastic Pro Drug administering coil-like device for insertion in body cavity of animal
US4994033A (en) * 1989-05-25 1991-02-19 Schneider (Usa) Inc. Intravascular drug delivery dilatation catheter
US5049132A (en) * 1990-01-08 1991-09-17 Cordis Corporation Balloon catheter for delivering therapeutic agents
US5221261A (en) * 1990-04-12 1993-06-22 Schneider (Usa) Inc. Radially expandable fixation member
US5102402A (en) * 1991-01-04 1992-04-07 Medtronic, Inc. Releasable coatings on balloon catheters
US5181911A (en) * 1991-04-22 1993-01-26 Shturman Technologies, Inc. Helical balloon perfusion angioplasty catheter
US5256146A (en) * 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature

Also Published As

Publication number Publication date
CA2182201A1 (en) 1995-08-03
JPH10500028A (en) 1998-01-06
EP0754072B1 (en) 2005-06-01
DE69534245T2 (en) 2006-01-26
DE69534245D1 (en) 2005-07-07
US5523092A (en) 1996-06-04
AU1868395A (en) 1995-08-15
WO1995020416A1 (en) 1995-08-03
EP0754072A4 (en) 1998-01-14
ES2243934T3 (en) 2005-12-01
AU682582B2 (en) 1997-10-09
EP0754072A1 (en) 1997-01-22
DK0754072T3 (en) 2005-09-05
US5709874A (en) 1998-01-20
PT754072E (en) 2005-10-31

Similar Documents

Publication Publication Date Title
DE69534232D1 (en) A device for femoral and tibiarresektion
DE69318027T2 (en) System for drug delivery
DE69133328D1 (en) Device for iontophoretic delivery
DE69434040D1 (en) Apparatus for intracardiac procedures
DE69333485D1 (en) An apparatus for extracorporeal blood treatment
DE69613113D1 (en) Independent motor device for the transdermal administration of drugs
DE69032788D1 (en) Apparatus for collating abutting forming bone structures
DE29501880U1 (en) A device for bone lengthening
AT429859T (en) An apparatus for attaching a vascular anastomosis
DE59510954D1 (en) A process for the preparation of pharmaceutical nanosuspensions
DE69530207D1 (en) Apparatus for impedance cardiography
DE69230336D1 (en) Device for demetallization
DE69428915T2 (en) Device for faltungsver- and -entschachterung
DE69119787D1 (en) A method and apparatus therefor apheresis
DE69733665D1 (en) Apparatus for tissue-irradiation
DE69316353T2 (en) surgical device
DE69316291T2 (en) An apparatus for solid phase extraction
DE69633957D1 (en) An implantable device for Antitachykardierierung
DE69526893D1 (en) Pen-shaped device for the administration of drugs having different dosage scale incremented
DE69530973D1 (en) A process for preparing finely divided pharmaceutical formulations
DE68922722D1 (en) Device for reduction of a fracture.
DE69319504D1 (en) Apparatus for inspecting a component
DE69000945D1 (en) Device for respiratory assistance.
DE69433277D1 (en) A device for light-activated therapy
DE69533085D1 (en) Apparatus for isolation of vibrating elements medical

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0754072

Country of ref document: EP

REN Ceased due to non-payment of the annual fee